Skip to main content
Top
Published in: Cancer Imaging 1/2015

Open Access 01-12-2015 | Research article

Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging

Authors: Xiaoguang Li, Yongshan Zhu, Houyi Kang, Yulong Zhang, Huaping Liang, Sumei Wang, Weiguo Zhang

Published in: Cancer Imaging | Issue 1/2015

Login to get access

Abstract

Background

Dynamic contrast-enhanced MRI (DCE-MRI) estimates vascular permeability of brain tumors, and susceptibility-weighted imaging (SWI) may demonstrate tumor vascularity by intratumoral susceptibility signals (ITSS). This study assessed volume transfer constant (Ktrans) accuracy, the volume of extravascular extracellular space (EES) per unit volume of tissue (Ve) derived from DCE-MRI, and the degree of ITSS in glioma grading.

Methods

Thirty-two patients with different glioma grades were enrolled in this retrospective study. Patients underwent DCE-MRI and non-contrast enhanced SWI by three-tesla scanning. Ktrans values, Ve, and the degree of ITSS in glioma were compared. Receiver operating characteristic (ROC) curve analysis determined diagnostic performances of Ktrans and Ve in glioma grading, and Spearman’s correlation analysis determined the associations between Ktrans, Ve, ITSS, and tumor grade.

Results

Ktrans and Ve values were significantly different between low grade gliomas (LGGs) and both high grade gliomas (HGGs) and grade II, III and IV gliomas (P < 0.01). The degree of ITSS of LGGs was lower than HGGs (P < 0.01), and the ITSS of grade II gliomas was lower than grade III or IV gliomas. Ktrans and Ve were correlated with glioma grade (P < 0.01), while ITSS was moderately correlated (P < 0.01). Ktrans values were moderately correlated with ITSS in the same segments (P < 0.01).

Conclusion

Ktrans and Ve values, and ITSS helped distinguish the differences between LGGs and HGGs and between grade II, III and IV gliomas. There was a moderate correlation between Ktrans and ITSS in the same tumor segments.
Literature
1.
go back to reference Tate MC, Aghi MK. Biology of angiogenesis and invasion in glioma. Neurotherapeutics. 2009;6:447–57. doi:10.1016/j.nurt.2009.04.001.CrossRefPubMed Tate MC, Aghi MK. Biology of angiogenesis and invasion in glioma. Neurotherapeutics. 2009;6:447–57. doi:10.1016/j.nurt.2009.04.001.CrossRefPubMed
2.
go back to reference Mahzouni P, Mohammadizadeh F, Mougouei K, Moghaddam NA, Chehrei A, Mesbah A. Determining the relationship between “microvessel density” and different grades of astrocytoma based on immunohistochemistry for “factor VIII–related antigen” (von Willebrand factor) expression in tumor microvessels. Indian J Pathol Microbiol. 2010;53:605–10. doi:10.4103/0377-4929.71996.CrossRefPubMed Mahzouni P, Mohammadizadeh F, Mougouei K, Moghaddam NA, Chehrei A, Mesbah A. Determining the relationship between “microvessel density” and different grades of astrocytoma based on immunohistochemistry for “factor VIII–related antigen” (von Willebrand factor) expression in tumor microvessels. Indian J Pathol Microbiol. 2010;53:605–10. doi:10.4103/0377-4929.71996.CrossRefPubMed
3.
go back to reference Onishi M, Ichikawa T, Kurozumi K, Date I. Angiogenesis and invasion in glioma. Brain Tumor Pathol. 2011;28:13–24. doi:10.1007/s10014-010-0007-z.CrossRefPubMed Onishi M, Ichikawa T, Kurozumi K, Date I. Angiogenesis and invasion in glioma. Brain Tumor Pathol. 2011;28:13–24. doi:10.1007/s10014-010-0007-z.CrossRefPubMed
4.
go back to reference Jackson A, Jayson GC, Li KL, Zhu XP, Checkley DR, Tessier JJ, et al. Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting astrocytoma. Br J Radiol. 2003;76:153–62.CrossRefPubMed Jackson A, Jayson GC, Li KL, Zhu XP, Checkley DR, Tessier JJ, et al. Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting astrocytoma. Br J Radiol. 2003;76:153–62.CrossRefPubMed
5.
go back to reference Lacerda S, Law M. Magnetic resonance perfusion and permeability imaging in brain tumors. Neuroimaging Clin North Am. 2009;19:527–57.CrossRef Lacerda S, Law M. Magnetic resonance perfusion and permeability imaging in brain tumors. Neuroimaging Clin North Am. 2009;19:527–57.CrossRef
6.
go back to reference Jia Z, Geng D, Liu Y, Chen X, Zhang J. Low-grade and anaplastic oligodendrogliomas: differences in tumour microvascular permeability evaluated with dynamic contrast-enhanced magnetic resonance imaging. J Clin Neurosci. 2013;20:1110–3. doi:10.1016/j.jocn.2012.09.019.CrossRefPubMed Jia Z, Geng D, Liu Y, Chen X, Zhang J. Low-grade and anaplastic oligodendrogliomas: differences in tumour microvascular permeability evaluated with dynamic contrast-enhanced magnetic resonance imaging. J Clin Neurosci. 2013;20:1110–3. doi:10.1016/j.jocn.2012.09.019.CrossRefPubMed
7.
go back to reference Jain R. Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications. NMR Biomed. 2013;26:1042–9. doi:10.1002/nbm.2994.CrossRefPubMed Jain R. Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications. NMR Biomed. 2013;26:1042–9. doi:10.1002/nbm.2994.CrossRefPubMed
8.
go back to reference Jia Z, Geng D, Xie T, Zhang J, Liu Y. Quantitative analysis of neovascular permeability in glioma by dynamic contrast-enhanced MR imaging. J Clin Neurosci. 2012;19:820–3. doi:10.1016/j.jocn.2011.08.030.CrossRefPubMed Jia Z, Geng D, Xie T, Zhang J, Liu Y. Quantitative analysis of neovascular permeability in glioma by dynamic contrast-enhanced MR imaging. J Clin Neurosci. 2012;19:820–3. doi:10.1016/j.jocn.2011.08.030.CrossRefPubMed
9.
go back to reference Kim HS, Jahng GH, Ryu CW, Kim SY. Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study. AJNR Am J Neuroradiol. 2009;30:1574–9. doi:10.3174/ajnr.A1635.CrossRefPubMed Kim HS, Jahng GH, Ryu CW, Kim SY. Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study. AJNR Am J Neuroradiol. 2009;30:1574–9. doi:10.3174/ajnr.A1635.CrossRefPubMed
10.
go back to reference Park MJ, Kim HS, Jahng GH, Ryu CW, Park SM, Kim SY. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging. AJNR Am J Neuroradiol. 2009;30:1402–8. doi:10.3174/ajnr.A1593.CrossRefPubMed Park MJ, Kim HS, Jahng GH, Ryu CW, Park SM, Kim SY. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging. AJNR Am J Neuroradiol. 2009;30:1402–8. doi:10.3174/ajnr.A1593.CrossRefPubMed
11.
go back to reference Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109.CrossRefPubMedCentralPubMed Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109.CrossRefPubMedCentralPubMed
12.
go back to reference Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1.Fundamental concepts. Magn Reson Med. 1991;17:357–67.CrossRefPubMed Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1.Fundamental concepts. Magn Reson Med. 1991;17:357–67.CrossRefPubMed
13.
go back to reference Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol. 1955;147:9–19. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol. 1955;147:9–19.
14.
go back to reference Jia ZZ, Geng DY, Liu Y, Chen XR, Zhang J. Microvascular permeability of brain astrocytoma with contrast-enhanced magnetic resonance imaging: correlation analysis with histopathologic grade. Chin Med J (Engl). 2013;126:1953–6. Jia ZZ, Geng DY, Liu Y, Chen XR, Zhang J. Microvascular permeability of brain astrocytoma with contrast-enhanced magnetic resonance imaging: correlation analysis with histopathologic grade. Chin Med J (Engl). 2013;126:1953–6.
15.
go back to reference Zhou J, Li N, Yang G, Zhu Y. Vascular patterns of brain tumors. Int J Surg Pathol. 2011;19:709–17. doi:10.1177/1066896911417710.CrossRefPubMed Zhou J, Li N, Yang G, Zhu Y. Vascular patterns of brain tumors. Int J Surg Pathol. 2011;19:709–17. doi:10.1177/1066896911417710.CrossRefPubMed
16.
go back to reference Nico B, Crivellato E, Guidolin D, Annese T, Longo V, Finato N, et al. Intussusceptive microvascular growth in human glioma. Clin Exp Med. 2010;10:93–8. doi:10.1007/s10238-009-0076-7.CrossRefPubMed Nico B, Crivellato E, Guidolin D, Annese T, Longo V, Finato N, et al. Intussusceptive microvascular growth in human glioma. Clin Exp Med. 2010;10:93–8. doi:10.1007/s10238-009-0076-7.CrossRefPubMed
17.
go back to reference Nakatsu MN, Sainson RC, Pérez-del-Pulgar S, Aoto JN, Aitkenhead M, Taylor KL, et al. VEGF(121) and VEGF(165) regulate blood vessel diameter through vascular endothelial growth factor receptor 2 in an in vitro angiogenesis model. Lab Invest. 2003;83:1873–85.CrossRefPubMed Nakatsu MN, Sainson RC, Pérez-del-Pulgar S, Aoto JN, Aitkenhead M, Taylor KL, et al. VEGF(121) and VEGF(165) regulate blood vessel diameter through vascular endothelial growth factor receptor 2 in an in vitro angiogenesis model. Lab Invest. 2003;83:1873–85.CrossRefPubMed
18.
go back to reference Zhang N, Zhang L, Qiu B. Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas. J Magn Reson Imaging. 2012;36:355–63. doi:10.1002/jmri.23675.CrossRefPubMedCentralPubMed Zhang N, Zhang L, Qiu B. Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas. J Magn Reson Imaging. 2012;36:355–63. doi:10.1002/jmri.23675.CrossRefPubMedCentralPubMed
19.
go back to reference Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10:223–32.CrossRefPubMed Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10:223–32.CrossRefPubMed
20.
go back to reference Aref M, Chaudhari AR, Bailey KL, Aref S, Wiener EC. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates. Magn Reson Imaging. 2008;26:1279–93. doi:10.1016/j.mri.2008.02.015.CrossRefPubMed Aref M, Chaudhari AR, Bailey KL, Aref S, Wiener EC. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates. Magn Reson Imaging. 2008;26:1279–93. doi:10.1016/j.mri.2008.02.015.CrossRefPubMed
21.
go back to reference Pike MM, Stoops CN, Langford CP, Akella NS, Nabors LB, Gillespie GY. High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI. Magn Reson Med. 2009;61:615–25. doi:10.1002/mrm.21931.CrossRefPubMedCentralPubMed Pike MM, Stoops CN, Langford CP, Akella NS, Nabors LB, Gillespie GY. High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI. Magn Reson Med. 2009;61:615–25. doi:10.1002/mrm.21931.CrossRefPubMedCentralPubMed
22.
go back to reference Siangprasertkij C, Navalitloha Y. A multivariate analysis of patients with glioma: a treatment outcome and prognostic factor for survival. J Med Assoc Thai. 2008;91:491–6.PubMed Siangprasertkij C, Navalitloha Y. A multivariate analysis of patients with glioma: a treatment outcome and prognostic factor for survival. J Med Assoc Thai. 2008;91:491–6.PubMed
23.
go back to reference Zhang W, Zhao J, Guo D, Zhong W, Shu J, Luo Y. Application of susceptibility weighted imaging in revealing intratumoral blood products and grading gliomas. J Radiol. 2010;91:485–90.CrossRefPubMed Zhang W, Zhao J, Guo D, Zhong W, Shu J, Luo Y. Application of susceptibility weighted imaging in revealing intratumoral blood products and grading gliomas. J Radiol. 2010;91:485–90.CrossRefPubMed
24.
go back to reference Hori M, Mori H, Aoki S, Abe O, Masumoto T, Kunimatsu S, et al. Three-dimensional susceptibility-weighted imaging at 3 T using various image analysis methods in the estimation of grading intracranial gliomas. Magn Reson Imaging. 2010;28:594–8. doi:10.1016/j.mri.2010.01.002.CrossRefPubMed Hori M, Mori H, Aoki S, Abe O, Masumoto T, Kunimatsu S, et al. Three-dimensional susceptibility-weighted imaging at 3 T using various image analysis methods in the estimation of grading intracranial gliomas. Magn Reson Imaging. 2010;28:594–8. doi:10.1016/j.mri.2010.01.002.CrossRefPubMed
25.
go back to reference Li C, Ai B, Li Y, Qi H, Wu L. Susceptibility-weighted imaging in grading brain astrocytomas. Eur J Radiol. 2010;75:e81–5. doi:10.1016/j.ejrad.2009.08.003.CrossRefPubMed Li C, Ai B, Li Y, Qi H, Wu L. Susceptibility-weighted imaging in grading brain astrocytomas. Eur J Radiol. 2010;75:e81–5. doi:10.1016/j.ejrad.2009.08.003.CrossRefPubMed
26.
go back to reference Bullitt E, Reardon DA, Smith JK. A review of micro- and macrovascular analyses in the assessment of tumor-associated vasculature as visualized by MR. Neuroimage. 2007;37 Suppl 1:S116–9.CrossRefPubMedCentralPubMed Bullitt E, Reardon DA, Smith JK. A review of micro- and macrovascular analyses in the assessment of tumor-associated vasculature as visualized by MR. Neuroimage. 2007;37 Suppl 1:S116–9.CrossRefPubMedCentralPubMed
27.
go back to reference Cha S, Johnson G, Wadghiri YZ, Jin O, Babb J, Zagzag D, et al. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med. 2003;49:848–55.CrossRefPubMed Cha S, Johnson G, Wadghiri YZ, Jin O, Babb J, Zagzag D, et al. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med. 2003;49:848–55.CrossRefPubMed
28.
go back to reference Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast- enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology. 2002;223:11–29.CrossRefPubMed Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast- enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology. 2002;223:11–29.CrossRefPubMed
Metadata
Title
Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging
Authors
Xiaoguang Li
Yongshan Zhu
Houyi Kang
Yulong Zhang
Huaping Liang
Sumei Wang
Weiguo Zhang
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Cancer Imaging / Issue 1/2015
Electronic ISSN: 1470-7330
DOI
https://doi.org/10.1186/s40644-015-0039-z

Other articles of this Issue 1/2015

Cancer Imaging 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine